N-deacetylated BMS-202 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate or derivative in the synthesis of more complex pharmaceutical compounds, particularly those targeting specific biological pathways or receptors. Its structural properties make it valuable for modifying and optimizing drug candidates to enhance their efficacy, selectivity, or pharmacokinetic profiles. Researchers often employ it in preclinical studies to investigate its potential therapeutic applications, especially in areas such as oncology or immunology, where targeted therapies are crucial. Additionally, it may be used in the development of small molecule inhibitors or modulators for various diseases, contributing to the advancement of novel treatments.